Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy

Detalles Bibliográficos
Autor principal: Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601881/
https://www.ncbi.nlm.nih.gov/pubmed/37901198
http://dx.doi.org/10.1159/000532023
_version_ 1785126283611471872
author Kudo, Masatoshi
author_facet Kudo, Masatoshi
author_sort Kudo, Masatoshi
collection PubMed
description
format Online
Article
Text
id pubmed-10601881
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-106018812023-10-27 Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy Kudo, Masatoshi Liver Cancer Editorial S. Karger AG 2023-07-28 /pmc/articles/PMC10601881/ /pubmed/37901198 http://dx.doi.org/10.1159/000532023 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Editorial
Kudo, Masatoshi
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
title Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
title_full Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
title_fullStr Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
title_full_unstemmed Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
title_short Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
title_sort drug-off criteria in patients with hepatocellular carcinoma who achieved clinical complete response after combination immunotherapy combined with locoregional therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601881/
https://www.ncbi.nlm.nih.gov/pubmed/37901198
http://dx.doi.org/10.1159/000532023
work_keys_str_mv AT kudomasatoshi drugoffcriteriainpatientswithhepatocellularcarcinomawhoachievedclinicalcompleteresponseaftercombinationimmunotherapycombinedwithlocoregionaltherapy

Ejemplares similares